At Sheppard, the technology transactions group specialises in various industry sectors, including healthcare IT, fashion, retail, and digital media, the team is well positioned to advise on IP licensing, strategic alliances, and joint ventures. The department is led by a trio of professionals, Brian Anderson; Michael Orlando; and David Schnapp. Anderson, based in the San Francisco office, is knowledgeable in intellectual property law, in San Diego Orlando handles outsourcing and commercial transactions, Schnapp, based in the New York practice, advises on information security and privacy.
Legal 500 Editorial commentary
Key clients
- Prospect Health
- Cytokinetics
- Cellares, Inc.
- Tharimmune, Inc.
- Green Line Train Protection System
- Red Cat Holdings
- NuxCel
- OneOncology
- Celularity
- American Society of Composers, Authors and Publishers (ASCAP)
Work highlights
Represented Piper Networks in a $100m technology services agreement with the Massachusetts Department of Transportation (MassDOT) and Massachusetts Bay Transportation Authority (MBTA) to implement the Green Line Train Protection System (GLTPS), which is part of the new Green Line Transformation Program.
Represented Cytokinetics in a research, development and licensing collaboration with a pharmaceutical company for the discovery, development and commercialization of certain cell therapy targets for multiple diseases using a drug discovery platform.
Represented Cellares in a joint development and collaboration agreement with Sony Corporation for the creation and supply of modular sorting and flow cytometry technology for integration into the Cellares cell shuttle automated cell therapy manufacturing platform, including a commercial supply agreement.
Practice head
Brian Anderson; Michael Orlando; Daniel Schnapp